Navigation Links
Varian Image-Guided Treatment Machines Selected for Major New Hospital on South Coast of England
Date:11/29/2007

PORTSMOUTH, England, Nov. 29 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: VAR) has this month been selected to provide state-of-the-art radiotherapy equipment for a major new hospital in Portsmouth, England. In one of the country's largest replacement projects since the investment waves of the UK government's Cancer Plan earlier this decade, the new Queen Alexandra Hospital will receive four high-energy Clinac(R) iX linear accelerators equipped with On-Board Imager(R) devices for advanced image-guided radiation therapy (IGRT) treatments.

Due to open in summer 2009, Queen Alexandra Hospital will enable all acute services currently spread across three sites to be brought together under one roof. This includes the current oncology center at St Mary's Hospital. The new facility will serve a population of 600,000 people.

Tony Palmer, the hospital's head of radiotherapy physics, says, "This new facility will mean we can offer local cancer patients treatments that are truly state-of-the-art internationally. We will also be one of the only NHS cancer centers in the UK with every one of our treatment machines equipped for 3D image-guided radiotherapy, which we feel is crucially important."

According to Mr Palmer, the desire to have all four machines equipped with On-Board Imager accessories was supported by the recommendations of the recent National Radiotherapy Advisory Group (NRAG) report on radiotherapy provision. "The NRAG report highlighted the importance of image-guidance on new linear accelerators and we want to be able to offer our patients the highest quality treatments on all machines, not just one or two," he said. "Our whole team of doctors, radiographers and physicists are very excited about the proposition of a new center with advanced technology for offering the best possible cancer treatments. This will enable us to precisely align the treatment beam with the tumor, using advanced imaging at the point of treatment with the ability to account for respiratory motion."

Clinicians at St Mary's Hospital are about to introduce highly-conformal intensity modulated radiotherapy (IMRT) treatments and this program will be expanded once the new machines are installed. An Acuity(TM) simulator at the current facility will be transferred to the new site next year and will have Varian's 4D respiratory compensation functionality added.

David Scott, Varian's UK sales manager, adds, "The team at Portsmouth undertook a very comprehensive evaluation of all aspects of the package including the ability to meet clinical and technical requirements as well as service provision and support. As the UK's leading supplier of radiotherapy equipment and software we were extremely pleased to have been selected on this basis over the incumbent supplier and are looking forward to working in partnership with Portsmouth to bring the world's most advanced radiotherapy treatments to patients on the south coast of England."

Prior to the advent of IGRT devices such as the On-Board Imager, radiation oncologists had to contend with variations in patient positioning and with respiratory motion by treating a larger margin of healthy tissue around the tumor. IGRT enables doctors to further minimize the volume of healthy tissue exposed to the treatment beam. Potentially, image data from IGRT tools like the On-Board Imager device will be used to note changes in tumor size and shape over a course of treatment, and make real-time adaptations to the treatment plan.

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 4,400 people who are located at manufacturing sites in North America and Europe and in its 60 sales and support offices around the world. For more information, visit http://www.varian.com/.

Forward Looking Statements

Statements in this press release regarding future business, events, plans, objectives, expectations, estimates, and other similar matters, including, but not limited to, statements using the terms "can" and "expect," constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements contained in this press release are subject to risks and uncertainties that could cause actual results to differ materially from those anticipated, including, but not limited to, the risks described in the company's Annual Report on Form 10-K and other reports filed from time to time by the Company with the Securities and Exchange Commission. These forward-looking statements represent the Company's judgment as of the date of this press release. The Company assumes no obligation to update or revise these forward-looking statements because of new information, future events, or otherwise.


'/>"/>
SOURCE Varian Medical Systems, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Cranberry Could Juice Up Ovarian Cancer Treatment
2. New Ovarian Cancer Drug Trial Under Way
3. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
4. Pelvic Exams Can Help Spot Ovarian Cancer
5. Study fuels debate over whether exercise and body size influence ovarian cancer risk
6. Experimental drug boosts survival in recurrent ovarian cancer
7. New Ovarian Cancer Biomarker Research Act Introduced
8. Common Early-Warning Symptoms of Ovarian Cancer Identified in CDC/Thomson Healthcare Study
9. More Fiber, Less Fat Help Prevent Ovarian Cancer
10. Media availability: low-fat dietary pattern may lower risk of ovarian cancer
11. The Silent Killer, Ovarian Cancer on Your Cancer Today (TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing ... their videos a whole new perspective by using the title layers in ProSlice ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
Breaking Medicine Technology: